CLINICAL_TRIALS
trial_result
· 2018-01-17
Clinical Trial Update: Study of Tocilizumab to Treat Polymyalgia Rheumatica [Phase 2]
Summary
Phase 2 clinical trial evaluating tocilizumab for treatment of polymyalgia rheumatica has completed with results posted in 2018.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hospital for Special Surgery, New York | Conditions: Polymyalgia Rheumatica (PMR) | Phase 2 | Status: COMPLETED | Results posted: 2018-01-17